CETP inhibitors and cardiovascular disease: Time to think again

Inhibition of cholesteryl ester transfer protein (CETP) lowers plasma low-density lipoprotein cholesterol concentration and raises high-density lipoprotein (HDL) cholesterol, suggesting it might prevent cardiovascular disease (CVD). From the outset, however, the concept has been controversial owing...

Descripción completa

Detalles Bibliográficos
Autor principal: Miller, Norman E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2014
Materias:
Opinion Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149245/
https://www.ncbi.nlm.nih.gov/pubmed/25187879
http://dx.doi.org/10.12688/f1000research.4396.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149245/
https://www.ncbi.nlm.nih.gov/pubmed/25187879
http://dx.doi.org/10.12688/f1000research.4396.1

Ejemplares similares